170 related articles for article (PubMed ID: 9000414)
1. Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation.
Bollow M; Taupitz M; Hamm B; Staks T; Wolf KJ; Weinmann HJ
Eur Radiol; 1997; 7(1):126-32. PubMed ID: 9000414
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR cholangiography: comparison of Gd-EOB-DTPA and Mn-DPDP in healthy volunteers.
Bae K; Na JB; Choi DS; Cho JM; Choi HC; Jeon KN; Park MJ; Choi HY; Kim JE; Chung SH
Br J Radiol; 2012 Sep; 85(1017):1250-4. PubMed ID: 22553292
[TBL] [Abstract][Full Text] [Related]
4. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L
Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011
[TBL] [Abstract][Full Text] [Related]
5. Early phase detection of bile leak after hepatobiliary surgery: value of Gd-EOB-DTPA-enhanced MR cholangiography.
Alegre Castellanos A; Molina Granados JF; Escribano Fernandez J; Gallardo Muñoz I; Triviño Tarradas Fde A
Abdom Imaging; 2012 Oct; 37(5):795-802. PubMed ID: 22213118
[TBL] [Abstract][Full Text] [Related]
6. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.
Reimer P; Rummeny EJ; Daldrup HE; Hesse T; Balzer T; Tombach B; Peters PE
Eur Radiol; 1997; 7(2):275-80. PubMed ID: 9038130
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage.
Kul M; Erden A; Düşünceli Atman E
Br J Radiol; 2017 Apr; 90(1072):20160847. PubMed ID: 28181823
[TBL] [Abstract][Full Text] [Related]
8. Optimal dose of hepatobiliary contrast agent for MR cholangiography: experimental study in rats.
Hirohashi S; Hirohashi R; Uchida H; Kitano S; Akira M; Ono W; Ohishi H; Kato N; Takahashi M; Miyazawa T
J Magn Reson Imaging; 1998; 8(4):847-52. PubMed ID: 9702886
[TBL] [Abstract][Full Text] [Related]
9. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P
Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
[TBL] [Abstract][Full Text] [Related]
10. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
11. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
Runge VM
J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
[TBL] [Abstract][Full Text] [Related]
12. [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].
Zangos S; Hammerstingl R; Mack MG; Straub R; Engelmann K; Eichler K; Balzer T; Vogl TJ
Rofo; 2001 Nov; 173(11):1034-40. PubMed ID: 11704914
[TBL] [Abstract][Full Text] [Related]
13. Effects of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on T2-weighted MRCP.
Nakamura Y; Ohmoto T; Saito T; Kajima T; Nishimaru E; Ito K
Magn Reson Med Sci; 2009; 8(4):143-8. PubMed ID: 20035122
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
15. MR imaging evaluation of liver enhancement by Gd-EOB-DTPA in selective and total bile duct obstruction in rats: correlation with serologic, microcholangiographic, and histologic findings.
Ni Y; Marchal G; Lukito G; Yu J; Mühler A; Baert AL
Radiology; 1994 Mar; 190(3):753-8. PubMed ID: 8115623
[TBL] [Abstract][Full Text] [Related]
16. Functional magnetic resonance cholangiography with Gd-EOB-DTPA: a study in healthy volunteers.
Lee SW; Cha SH; Chung HH; Kim KH; Yeom SK; Seo BK; Je BK; Kim BH
Magn Reson Imaging; 2014 May; 32(4):385-91. PubMed ID: 24529920
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
19. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA for preoperative biliary mapping: correlation with intraoperative cholangiography.
Lee Y; Kim SY; Kim KW; Lee SS; Park SH; Byun JH; Lee MG
Acta Radiol; 2015 Jul; 56(7):773-81. PubMed ID: 25080516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
